Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of acquired Fanconi syndrome induced by zoledronic acid.
Yoshinami T, Yagi T, Sakai D, Sugimoto N, Imamura F. Yoshinami T, et al. Among authors: sakai d. Intern Med. 2011;50(9):1075-9. doi: 10.2169/internalmedicine.50.4855. Epub 2011 May 1. Intern Med. 2011. PMID: 21532237 Free article.
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, Akazawa Y, Sakai D, Yamamoto S, Hamanaka Y, Masaie H, Sugimoto N, Yoshida H, Tomita Y, Imamura F. Yagi T, et al. Among authors: sakai d. Int J Hematol. 2012 Feb;95(2):214-6. doi: 10.1007/s12185-011-0979-4. Epub 2011 Dec 16. Int J Hematol. 2012. PMID: 22170229
[Cancer stem cells depend on their own niche].
Kano Y, Ishii H, Konno M, Ohta K, Nishikawa S, Fukusumi T, Hamabe A, Hasegawa S, Ogawa H, Ozaki M, Noguchi Y, Sakai D, Haraguchi N, Kudo T, Satoh T, Doki Y, Mori M. Kano Y, et al. Among authors: sakai d. Gan To Kagaku Ryoho. 2013 Apr;40(4):419-23. Gan To Kagaku Ryoho. 2013. PMID: 23848007 Review. Japanese.
A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer.
Eguchi H, Nagano H, Kobayashi S, Kawamoto K, Wada H, Hama N, Tomimaru Y, Akita H, Sakai D, Satoh T, Kudo T, Isohashi F, Mori M, Doki Y. Eguchi H, et al. Among authors: sakai d. Cancer Chemother Pharmacol. 2014 Feb;73(2):309-15. doi: 10.1007/s00280-013-2357-9. Epub 2013 Nov 21. Cancer Chemother Pharmacol. 2014. PMID: 24258457 Clinical Trial.
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.
Kobayashi S, Nagano H, Sakai D, Eguchi H, Hatano E, Kanai M, Seo S, Taura K, Fujiwara Y, Ajiki T, Takemura S, Kubo S, Yanagimoto H, Toyokawa H, Tsuji A, Terajima H, Morita S, Ioka T. Kobayashi S, et al. Among authors: sakai d. Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709. doi: 10.1007/s00280-014-2543-4. Epub 2014 Jul 30. Cancer Chemother Pharmacol. 2014. PMID: 25074036 Clinical Trial.
619 results